BIOA — Bioiasis AD Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Bioiasis AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.002 | 0.063 | 0.02 | -2.52 | -0.037 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.025 | 0.01 | -0.008 | -6.19 | -0.106 |
| Other Investing Cash Flow Items | — | 0 | 0 | -5.91 | 0.664 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0 | 0 | -5.91 | 0.664 |
| Financing Cash Flow Items | — | 0 | 0 | -0.27 | -0.697 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 0 | 0 | 12.2 | -0.559 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.025 | 0.01 | -0.008 | 0.057 | -0.001 |